Comments
Loading...

Dyne Therapeutics

DYNNASDAQ
Logo brought to you by Benzinga Data
$36.08
1.745.05%
Last update: 10:54 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$66.00
Lowest Price Target1
$42.00
Consensus Price Target1
$51.40

Dyne Therapeutics (NASDAQ:DYN) Stock, Analyst Ratings, Price Targets, Forecasts

Dyne Therapeutics Inc has a consensus price target of $51.4 based on the ratings of 10 analysts. The high is $66 issued by Stifel on August 16, 2024. The low is $42 issued by Chardan Capital on May 21, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Oppenheimer, and Stifel on September 4, 2024, September 3, 2024, and August 16, 2024, respectively. With an average price target of $58.67 between HC Wainwright & Co., Oppenheimer, and Stifel, there's an implied 69.56% upside for Dyne Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
1
Jul
2
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer
Stifel
Guggenheim
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Dyne Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Dyne Therapeutics (DYN) stock?

A

The latest price target for Dyne Therapeutics (NASDAQ:DYN) was reported by HC Wainwright & Co. on September 4, 2024. The analyst firm set a price target for $55.00 expecting DYN to rise to within 12 months (a possible 52.46% upside). 24 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Dyne Therapeutics (DYN)?

A

The latest analyst rating for Dyne Therapeutics (NASDAQ:DYN) was provided by HC Wainwright & Co., and Dyne Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Dyne Therapeutics (DYN)?

A

The last upgrade for Dyne Therapeutics Inc happened on February 27, 2023 when Raymond James raised their price target to $27. Raymond James previously had an outperform for Dyne Therapeutics Inc.

Q

When was the last downgrade for Dyne Therapeutics (DYN)?

A

There is no last downgrade for Dyne Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Dyne Therapeutics (DYN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dyne Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dyne Therapeutics was filed on September 4, 2024 so you should expect the next rating to be made available sometime around September 4, 2025.

Q

Is the Analyst Rating Dyne Therapeutics (DYN) correct?

A

While ratings are subjective and will change, the latest Dyne Therapeutics (DYN) rating was a reiterated with a price target of $55.00 to $55.00. The current price Dyne Therapeutics (DYN) is trading at is $36.08, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch